Source-grounded facts extracted from HUMANA INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
HUMANA INC reported the year ending December 31, 2026 results: EPS at least $9.00. Guidance reaffirmed.
“Affirms Adjusted FY 2026 GAAP EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $8.36' from the previous estimate of 'at least $8.89'”
HUMANA INC reported the quarter ended March 31, 2026 results: EPS $9.83.
“Reports 1Q26 earnings per share (EPS) of $9.83 on a GAAP basis, Adjusted EPS of $10.31”
HUMANA INC incurred senior notes of $1.0 billion aggregate principal amount of its 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056 with The Bank of New York Mellon Trust Company, N.A., as trustee at annual rate of 6.625% to, but excluding September 15, 2031, following which such maturing September 15, 2056.
“The Subordinated Notes bear interest at an annual rate of 6.625% to, but excluding September 15, 2031, following which such rate will reset in successive five-year periods until maturity at a rate equal to Five-year U.S. Treasury Rate as of the Reset Interest Determination Date (each as defined in the First Supplemental Indenture) plus 2.891%; provided, that any such interest rate will not reset below 6.625%.”
HUMANA INC entered into First Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-09).
“as supplemented by a first supplemental indenture, dated as of March 9, 2026, by and between the Company and the Trustee relating to the Subordinated Notes (the “First Supplemental Indenture””
HUMANA INC entered into Original Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-05).
“The Subordinated Notes were issued under an amended and restated indenture dated as of March 5, 2026, by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”) (the “Original Indenture")”
HUMANA INC entered into Underwriting Agreement with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC valued at $1.0 billion (effective 2026-03-05).
“On March 5, 2026, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $1.0 billion aggregate principal amount of its 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056”
Gordon Smith was elected as director at HUMANA INC.
“Effective October 23, 2024, the Board of Directors (the “Board”) of Humana Inc. (the “Company”) expanded its number of authorized directors from eleven to twelve and elected Gordon Smith as a director of the Company.”
James A. Rechtin was elected as Director at HUMANA INC.
“Mr. Rechtin will be elected to the Company’s Board of Directors”
James A. Rechtin was appointed as President and Chief Executive Officer at HUMANA INC.
“James A. Rechtin would become President and Chief Executive Officer at that time.”
Bruce D. Broussard resigned as Director at HUMANA INC.
“The Company also expects that Mr. Broussard will resign from the Company’s Board of Directors, and Mr. Rechtin will be elected to the Company’s Board of Directors, in each case effective as of July 1, 2024.”
Bruce D. Broussard departed as Chief Executive Officer at HUMANA INC.
“Bruce D. Broussard, Chief Executive Officer, would be stepping down from that role in the latter half of 2024”
HUMANA INC reported year ending December 31, 2024 results: EPS $16.00. Guidance reaffirmed.
“Humana revised its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to approximately $13.93 from approximately $14.87, while affirming its Adjusted EPS guidance of approximately $16.00.”
HUMANA INC reported quarter ended March 31, 2024 results: revenue $29,611, EPS $6.11.
“and segment statistics comparing 1Q24 to 1Q23 follows. 2 Humana Inc. Summary of Results ($ in millions, except per share amounts) 1Q24 (a) 1Q23 (a) CONSOLIDATED Revenues $29,611 $26,742 Revenues - Adjusted (non-GAAP) $29,332 $25,652 Pretax results $1,014 $1,614 Pretax results - Adjusted (non-GAAP) $1,191 $1,552 EPS $6.11 $9.87 EPS - Adjusted (non-GAAP)”
HUMANA INC shareholders approved Stockholder proposal on simple majority vote at the 2024-04-18 meeting.
“Proposal #6 For Against Abstained Broker Non-Votes Stockholder proposal on simple majority vote 49,977,350 47,454,113 376,486 5,572,071”
HUMANA INC shareholders approved Amendment to the Company’s Restated Certificate of Incorporation to eliminate supermajority voting requirement in connection with certain transactions at the 2024-04-18 meeting.
“Proposal #5 For Against Abstained Broker Non-Votes Amendment to the Company’s Restated Certificate of Incorporation to eliminate supermajority voting requirement in connection with certain transactions 96,562,716 1,076,542 168,691 5,572,071”
HUMANA INC shareholders approved Amendment to the Company’s Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law at the 2024-04-18 meeting.
“Proposal #4 For Against Abstained Broker Non-Votes Amendment to the Company’s Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law 83,361,627 14,226,255 220,067 5,572,071”
HUMANA INC shareholders approved Board proposal regarding advisory approval of the Company’s executive compensation at the 2024-04-18 meeting.
“Proposal #3 For Against Abstained Broker Non-Votes Board proposal regarding advisory approval of the Company’s executive compensation 89,131,142 8,422,934 253,873 5,572,071”
HUMANA INC shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024 at the 2024-04-18 meeting.
“Proposal #2 For Against Abstained Broker Non-Votes Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024 95,761,126 7,454,977 163,917 N/A”
HUMANA INC shareholders approved Election of Directors at the 2024-04-18 meeting.
“Proposal #1 : The final results of the election of directors were as follows:”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.